Publication | Closed Access
Outer Membrane Protein Vesicle Vaccines for Meningococcal Disease
79
Citations
40
References
2003
Year
VaccinationVaccinologyCross-protectionOuter-membrane VesicleMucosal VaccinationReverse VaccinologyVaccine TargetMeningococcal DiseaseImmunologyCell-surface Outer-membrane ProteinsMicrobiologyInfection ControlVaccine DesignBacterial MeningitisMedicineVaccine ResearchClinical MicrobiologyBactericidal Antibodies
Alternative strategies exist for prevention of group B Neisseria meningitidis (meningococcal) disease through vaccination (see Chapters 5 , 8 , 13 , 14 in this volume). However, the most promising approach to date has been the use of outer-membrane vesicle (OMV) vaccines for induction of bactericidal antibodies against cell-surface outer-membrane proteins (OMPs).
| Year | Citations | |
|---|---|---|
Page 1
Page 1